Literature DB >> 10576040

Effect of immunosuppressive therapy on graft half-life projections. The Collaborative Transplant Study.

G Opelz1.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10576040     DOI: 10.1016/s0041-1345(99)00791-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

2.  Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases.

Authors:  Haruna Kawamura; Satohiro Matsumoto; Noriyuki Nakamura; Hiroyuki Miyatani; Hirosato Mashima
Journal:  Am J Case Rep       Date:  2017-04-15

3.  Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan.

Authors:  Yi-Chang Lin; Chien-Sung Tsai; I-Hsun Li; Yi-Ting Tsai; Tien-Yu Huang; Kwai-Fong Lee; Chih-Sheng Lin; Jui-Hu Shih; Li-Ting Kao
Journal:  Front Pharmacol       Date:  2019-09-19       Impact factor: 5.810

Review 4.  Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipients.

Authors:  Eric Thervet; Frank Martinez; Christophe Legendre
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

5.  Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study.

Authors:  Satohiro Matsumoto; Haruna Kawamura; Takeshi Nishikawa; Noriyoshi Sagihara; Hiroyuki Miyatani; Hirosato Mashima
Journal:  Clin Exp Gastroenterol       Date:  2017-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.